KRAS p.G12C
About
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | KRAS p.G12C | Non-Small Cell Lung Cancer | Adagrasib | |
| FDA (1) HC (1) | KRAS p.G12C | Non-Small Cell Lung Cancer | Sotorasib | |
| FDA (1) | KRAS p.G12C | Colorectal Adenocarcinoma | Adagrasib, Cetuximab | |
| FDA (1) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |